Menetrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach

被引:79
作者
Coffey, Robert J.
Washington, Mary Kay
Corless, Christopher L.
Heinrich, Michael C.
机构
[1] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Cell & Dev Biol, Med Ctr, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[4] Nashville Vet Affairs Med Ctr, Nashville, TN USA
[5] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA
[6] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA
[7] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA
[8] Portland VA Med Ctr, Portland, OR USA
关键词
D O I
10.1172/JCI30491
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Menetrier disease and gastrointestinal stromal tumors (GISTs) are hyperproliferative disorders of the stomach caused by dysregulated receptor tyrosine kinases (RTKs). In Menetrier disease, overexpression of TGF-alpha, a ligand for the RTK EGFR, results in selective expansion of surface mucous cells in the body and fundus of the stomach. In GISTs, somatic mutations of the genes encoding the RTK KIT (or PDGFRA in a minority of cases) result in constitutive kinase activity and neoplastic transformation of gut pacemaker cells (interstitial cells of Cajal). On the basis of the involvement of these RTKs in the pathogenesis of these disorders, Menetrier disease patients have been effectively treated with a blocking monoclonal antibody specific for EGFR and GIST patients with KIT and PDGFRA tyrosine kinase inhibitors.
引用
收藏
页码:70 / 80
页数:11
相关论文
共 111 条
[41]   Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors [J].
Hirota, S ;
Ohashi, A ;
Nishida, T ;
Isozaki, K ;
Kinoshita, K ;
Shinomura, Y ;
Kitamura, Y .
GASTROENTEROLOGY, 2003, 125 (03) :660-667
[42]   THE HEMATOPOIETIC GROWTH FACTOR-KL IS ENCODED BY THE SI-LOCUS AND IS THE LIGAND OF THE C-KIT RECEPTOR, THE GENE-PRODUCT OF THE W-LOCUS [J].
HUANG, E ;
NOCKA, K ;
BEIER, DR ;
CHU, TY ;
BUCK, J ;
LAHM, HW ;
WELLNER, D ;
LEDER, P ;
BESMER, P .
CELL, 1990, 63 (01) :225-233
[43]   Protein tyrosine kinase structure and function [J].
Hubbard, SR ;
Till, JH .
ANNUAL REVIEW OF BIOCHEMISTRY, 2000, 69 :373-398
[44]  
HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0
[45]   Management of malignant gastrointestinal stromal tumours [J].
Joensuu, H ;
Fletcher, C ;
Dimitrijevic, S ;
Silberman, S ;
Roberts, P ;
Demetri, G .
LANCET ONCOLOGY, 2002, 3 (11) :655-664
[46]   Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. [J].
Joensuu, H ;
Roberts, PJ ;
Sarlomo-Rikala, M ;
Andersson, LC ;
Tervahartiala, P ;
Tuveson, D ;
Silberman, SL ;
Capdeville, R ;
Dimitrijevic, S ;
Druker, B ;
Demetri, GD .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1052-1056
[47]  
JOHNSON LR, 1976, GASTROENTEROLOGY, V70, P278
[48]   DYNAMICS OF EPITHELIAL-CELLS IN THE CORPUS OF THE MOUSE STOMACH .2. OUTWARD MIGRATION OF PIT CELLS [J].
KARAM, SM ;
LEBLOND, CP .
ANATOMICAL RECORD, 1993, 236 (02) :280-296
[49]   DYNAMICS OF EPITHELIAL-CELLS IN THE CORPUS OF THE MOUSE STOMACH .4. BIDIRECTIONAL MIGRATION OF PARIETAL-CELLS ENDING IN THEIR GRADUAL DEGENERATION AND LOSS [J].
KARAM, SM .
ANATOMICAL RECORD, 1993, 236 (02) :314-332
[50]   DYNAMICS OF EPITHELIAL-CELLS IN THE CORPUS OF THE MOUSE STOMACH .5. BEHAVIOR OF ENTERO-ENDOCRINE AND CAVEOLATED CELLS - GENERAL CONCLUSIONS ON CELL-KINETICS IN THE OXYNTIC EPITHELIUM [J].
KARAM, SM ;
LEBLOND, CP .
ANATOMICAL RECORD, 1993, 236 (02) :333-340